These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6772746)

  • 1. Scanning dose and detection of thyroid metastases.
    Coakley AJ; Page CJ; Croft D
    J Nucl Med; 1980 Aug; 21(8):803-4. PubMed ID: 6772746
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of metastatic thyroid carcinoma after the administration of a therapeutic dose of 131-iodine.
    Preisman RA; Halpern S
    Eur J Nucl Med; 1978; 3(1):69-70. PubMed ID: 753625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of posttherapeutic scintigraphy for the demonstration of distant metastases of differentiated carcinomas of the thyroid gland].
    Moser E; Hahn D; Wendt T; Büll U
    Strahlentherapie; 1983 Apr; 159(4):217-23. PubMed ID: 6857735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Euthyroidism due to functioning metastasis of a follicular carcinoma of thyroid origin].
    Diez Jiménez L; Gómez Embuena A; Manrique Legaz AJ; Ortuno de Solo MB; Arnaiz Bueno F
    Rev Clin Esp; 1978 Oct; 151(2):159-61. PubMed ID: 740986
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum thyroglobulin in the management of thyroid cancer.
    Blahd WH
    J Nucl Med; 1990 Nov; 31(11):1771-3. PubMed ID: 2121914
    [No Abstract]   [Full Text] [Related]  

  • 6. [Functional state of the late metastases in thyroid gland cancer (according to profile scanning data)].
    Kiseleva ES; Sedrakian RL; Starinskiĭ VV; Reznichenko FM
    Med Radiol (Mosk); 1975 Feb; 20(2):16-22. PubMed ID: 805888
    [No Abstract]   [Full Text] [Related]  

  • 7. [Principles of radionuclide methods of diagnosing and treating primary thyroid cancer and its metastases].
    Purizhanskiĭ II; Lushina LI; Lyzhina VD; Lisenkov PI
    Med Radiol (Mosk); 1982 Oct; 27(10):61-6. PubMed ID: 7176859
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rational basis for the therapy of differentiated carcinoma of the thyroid].
    Nosari I; Tidone L; Ferrari L; Montini M; Sileo F; Pagani G; Gelli D
    Recenti Prog Med; 1984; 75(7-8):758-74. PubMed ID: 6438737
    [No Abstract]   [Full Text] [Related]  

  • 9. The case for obtaining a diagnostic whole-body scan prior to iodine 131 treatment of differentiated thyroid cancer.
    McDougall IR
    Thyroid; 2009 Aug; 19(8):811-3. PubMed ID: 19645613
    [No Abstract]   [Full Text] [Related]  

  • 10. [Localization and evaluation of metastases of thyroid gland tumors with profile scanning].
    Hupka S; Skupenová A; Simko S; Licková M
    Bratisl Lek Listy; 1968 Aug; 50(2):221-8. PubMed ID: 4176496
    [No Abstract]   [Full Text] [Related]  

  • 11. The low utility of pretherapy scans in thyroid cancer patients.
    Schlumberger MJ; Pacini F
    Thyroid; 2009 Aug; 19(8):815-6. PubMed ID: 19645614
    [No Abstract]   [Full Text] [Related]  

  • 12. Gallbladder visualization during post-therapy iodine-131 imaging of thyroid carcinoma.
    Achong DM; Oates E; Lee SL; Doherty FJ
    J Nucl Med; 1991 Dec; 32(12):2275-7. PubMed ID: 1744714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral edema following iodine-131 therapy for thyroid carcinoma metastatic to the brain.
    Datz FL
    J Nucl Med; 1986 May; 27(5):637-40. PubMed ID: 3712081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical value of serum thyroglobulin and 131I-whole body retention measurements in the diagnosis of metastases from differentiated thyroid carcinoma (author's transl)].
    Weissel M; Bergmann H; Höfer R
    Acta Med Austriaca; 1980; 7(4-5):114-9. PubMed ID: 7246011
    [No Abstract]   [Full Text] [Related]  

  • 15. [Skeletal metastases from differentiated thyroid carcinomas. Radiographic appearances, scans, course during treatment].
    Wiebe V; Erbe W
    Fortschr Geb Rontgenstr Nuklearmed; 1973 Mar; 118(3):313-9. PubMed ID: 4691617
    [No Abstract]   [Full Text] [Related]  

  • 16. Two artifacts in the (131)I whole body post treatment scan in a thyroid cancer patient.
    Sood A; Seam RK; Sood V; Kumar R
    Hell J Nucl Med; 2007; 10(3):184. PubMed ID: 18084663
    [No Abstract]   [Full Text] [Related]  

  • 17. Scanning dose and the detection of thyroid metastases.
    Halpern SE; Preisman R; Hagan PL
    J Nucl Med; 1979 Oct; 20(10):1099-100. PubMed ID: 536764
    [No Abstract]   [Full Text] [Related]  

  • 18. [Detection and treatment of thyroid cancer metastases with iodine-131].
    Swyngedauw J; Madelain M; Rohart J; Lequint A
    Lille Med; 1971; 16(6):826-34. PubMed ID: 5112242
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyroid stunning after (131)I diagnostic whole-body scanning.
    McMenemin RM; Hilditch TE; Dempsey MF; Reed NS
    J Nucl Med; 2001 Jun; 42(6):986-7. PubMed ID: 11390566
    [No Abstract]   [Full Text] [Related]  

  • 20. Radioiodine uptake in normal female breasts and liver of a patient with differentiated thyroid cancer imaged by whole body scanning.
    Perros P; Mallick UK; Fenwick JD
    Thyroid; 2003 May; 13(5):511. PubMed ID: 12855021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.